{
    "organizations": [],
    "uuid": "dd86de5e24d056fa233bdb371ff6a99ebb8976cc",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-rovi-signs-agreement-with-hikma-to/brief-rovi-signs-agreement-with-hikma-to-distribute-its-enoxaparin-biosimilar-idUSFWN1S1082",
    "ord_in_thread": 0,
    "title": "BRIEF-Rovi Signs Agreement With Hikma To Distribute Its Enoxaparin Biosimilar",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Laboratorios Farmaceuticos Rovi SA :\n* SAYS SIGNS AGREEMENT WITH HIKMA TO DISTRIBUTE AND MARKET ITS ENOXAPARIN BIOSIMILAR Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-24T16:02:00.000+03:00",
    "crawled": "2018-04-25T14:51:08.023+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "laboratorios",
        "farmaceuticos",
        "rovi",
        "sa",
        "say",
        "sign",
        "agreement",
        "hikma",
        "distribute",
        "market",
        "enoxaparin",
        "biosimilar",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}